Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $32.3000 (-0.95%) ($32.0000 - $32.9000) on Thu. May. 4, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.24% (three month average) | RSI | 54 | Latest Price | $32.3000(-0.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.4% a day on average for past five trading days. | Weekly Trend | CAPR advances 2.1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWI(7%) PEJ(7%) SKYY(7%) XLF(7%) ARKK(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.12% in a week (0% probabilities). GDX(-7%) TLT(-6%) GLD(-6%) VIXM(-5%) SLV(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.12% (StdDev 4.24%) | Hourly BBV | 0 () | Intraday Trend | 0.9% | | | |
|
5 Day Moving Average | $32.14(0.5%) | 10 Day Moving Average | $31.83(1.48%) | 20 Day Moving Average | $31.16(3.66%) | To recent high | -5% | To recent low | 34.6% | Market Cap | $636m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |